Why should you buy UiPath shares now?
Find the latest UiPath Inc. (PATH) stock quote, history, news and other vital information to help you with your stock trading and investing.
What is the ticker symbol for UiPath?
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.
What is UiPath?
Apr 24, 2022 · Here are some recent quotes from research analysts about UiPath stock: 1. According to Zacks Investment Research, "UiPath Inc. offers an end-to-end platform for automation, combining Robotic Process Automation solution for digital business operations. UiPath Inc. is based in New York, United States. " (4/7/2022) 2.
Is UiPath stock overvalued or undervalued?
Real time UiPath Inc. (PATH) stock price quote, stock graph, news & analysis.
See more
2 days ago · UiPath Stock is Nearing Rock Bottom Down Here. Robotic process automation (RPA) platform provider UiPath (NASDAQ: PATH) stock has been getting crushed to new lows ever since hitting highs of $90 nearly a year ago. 3 weeks ago - MarketBeat.
Why are UiPath shares falling?
Is Path a good stock to buy?
Is UiPath stock overvalued?
Can you buy UiPath shares?
Compare special offers, low fees and a wide range of types of investments among top trading platforms. Trade stocks in the app or online with $0 commissions.
Is PATH a buy or sell?
...
Momentum Scorecard. More Info.
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 24.97% |
| 2 | Buy | 18.45% |
| 3 | Hold | 10.03% |
| 4 | Sell | 5.70% |
Is UiPath a buy Zacks?
Is it good to invest in UiPath?
However, its decelerating growth, declining margins, ongoing dilution, and unattractive valuation make it tough to recommend -- even though it's trading at a significant discount to its IPO price. Leo Sun has no position in any of the stocks mentioned.Mar 31, 2022
Is UiPath a good stock?
Who invested in UiPath?
Does UiPath stock grow?
Nevertheless, investors should note that UiPath is managing the business for ARR growth (annual recurring revenue). On the ARR side, the results were even more impressive with 59% growth to $925M. UiPath added a record $107M in net new ARR during the quarter, an increase of 72% YOY.Mar 31, 2022
How do I invest in UiPath?
- Create an account or log in and go to our trading platform.
- Search for 'UiPath'
- Select 'buy' in the deal ticket.
- Set your position size and take steps to manage your risk.
- Open and monitor your long position.
How can I buy UiPath stock from India?
Is UiPath a buy right now?
21 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for UiPath in the last twelve months. There are currently 2 sell rat...
How has UiPath's stock price been impacted by COVID-19?
UiPath's stock was trading at $18.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Si...
When is UiPath's next earnings date?
UiPath is scheduled to release its next quarterly earnings announcement on Wednesday, March 30th 2022. View our earnings forecast for UiPath .
How can I listen to UiPath's earnings call?
UiPath will be holding an earnings conference call on Wednesday, March 30th at 5:00 PM Eastern. Interested parties can register for or listen to th...
How were UiPath's earnings last quarter?
UiPath Inc. (NASDAQ:PATH) posted its earnings results on Wednesday, December, 8th. The healthcare company reported ($0.17) earnings per share for t...
What price target have analysts set for PATH?
21 brokerages have issued 12 month price targets for UiPath's stock. Their forecasts range from $40.00 to $85.00. On average, they anticipate UiPat...
What are Wall Street analysts saying about UiPath stock?
Here are some recent quotes from research analysts about UiPath stock: 1. According to Zacks Investment Research, "UiPath Inc. offers an end-to-en...
Who are UiPath's key executives?
UiPath's management team includes the following people: Mr. Daniel Solomon Dines , Co-Founder, CEO, & Chairman (Age 49) Mr. Marius Tirca , Co-F...
Who are some of UiPath's key competitors?
Some companies that are related to UiPath include NetEase (NTES) , VMware (VMW) , CrowdStrike (CRWD) , Synopsys (SNPS) , Autodesk (ADSK) , Da...
Is UiPath a buy right now?
What stocks does MarketBeat like better than UiPath?
21 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for UiPath in the last twelve months. There are currently 2 sell ratings, 11 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" UiPath stock.
When is UiPath's next earnings date?
Wall Street analysts have given UiPath a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but UiPath wasn't one of them.
How can I listen to UiPath's earnings call?
UiPath is scheduled to release its next quarterly earnings announcement on Tuesday, September 7th 2021.#N#View our earnings forecast for UiPath.
How were UiPath's earnings last quarter?
UiPath will be holding an earnings conference call on Tuesday, September 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 201-612-7415.
How has UiPath's stock price been impacted by Coronavirus (COVID-19)?
UiPath Inc. (NASDAQ:PATH) announced its quarterly earnings results on Monday, June, 7th. The healthcare company reported $0.02 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.05) by $0.07.
What guidance has UiPath issued on next quarter's earnings?
UiPath's stock was trading at $18.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PATH stock has increased by 260.9% and is now trading at $64.97.#N#View which stocks have been most impacted by COVID-19.
About PATH
UiPath issued an update on its second quarter 2022 earnings guidance on Tuesday, July, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $180 million-$185 million.
Financial Performance
UiPath's platform is designed to transform the way humans work. We provide our customers with a robust set of capabilities to discover automation opportunities and build, manage, run, engage, measure, and govern automations across departments within an organization.
News
In 2020, UiPath's revenue was $607.64 million, an increase of 80.76% compared to the previous year's $336.16 million. Losses were -$92.39 million, -82.23% less than in 2019.
History
Software-based bots are empowering knowledge workers with new ways to automate mind-numbing tasks.
Products
UiPath was founded in 2005 in Bucharest, Romania as DeskOver, by Romanian entrepreneurs Daniel Dines and Marius Tîrcă.
